Republicans Plan to Tackle FDA User Fee Reauthorization by June

February 14, 2017

Congressional Republicans are planning to complete work this summer — possibly the end of June — on a legislation package reauthorizing the FDA’s user fee programs.

Work on FDA user fees will follow a similar timeline to the last user fee agreement, according to a source on Capitol Hill. The previous agreement was signed into law on July 9, 2012.

The user fee programs — covering prescription drugs, generics and medical device reviews through 2022 — need to be reauthorized before the end of September. Sharing that deadline are appropriations for fiscal 2018 and the extension of the debt ceiling. — Conor Hale

View today's stories